FindTrial
Sign In

Study for the correlation between menopausal hormone replacement therapy and coagulation function

Study for the correlation between menopausal hormone replacement therapy and coagulation function

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020884
Enrollment
Unknown
Registered
2019-01-21
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause syndrome

Interventions

Perimenopause group:nil
Early postmenopause group:nil
Late postmenopause group:nil

Sponsors

Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) women aged 40-65 years old; (2) menopause: perimenopause, early postmenopause, late postmenopause (according to STRAW+10 staging system); (3) women who require hormone replacement therapy to improve clinical symptoms.

Exclusion criteria

Exclusion criteria: (1) history of stroke, thrombosis or anticoagulants such as aspirin and warfarin; (2) history of malignant tumors; (3) abnormal liver and kidney functions; (4) contraindications to estrogen therapy; (5) pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
Thrombelastogram;Sex hormones;serum lipid;blood glucose;Menopause scale;—

Countries

China

Contacts

Public ContactMinfang Tao

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

taomf@sjtu.edu.cn+86 18930173041

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026